T lymphocytes are involved in most specific immune defenses against microorganisms, parasites and toxic substances. In addition, they play pivotal roles in allergy, autoimmunity and the rejection of surgical transplants. These cells thus contribute in both positive and negative ways to many disease states. The long term goals of this proposal are to understand the molecular mechanisms of antigen recognition by human T lymphocytes, and to chemically define the role that products of the Major Histocompatibility Complex (MHC) play in this process. At present we have some understanding of the components involved but almost no appreciation of the way they work or interact with each other. The response of cloned human cytolytic T cells (CTL) to allogeneic class I antigens (HLA-A,B) will be studied as this represents a simplified system for which key reagents, i.e., cloned genes, purified HLA-A,B antigens and well defined monoclonal antibodies, are available. Two distinct strategies encompassing three specific aims are proposed.
In aim 1 in vitro mutagenesis will be used to produce HLA-A,B molecules that have alterations in regions that have been conserved during evolution. Their structural and functional properties as targets for allogeneic CTL will be examined. This will identify the """"""""active site"""""""" of the HLA-A,B molecule for productive interaction with any T cell that is """"""""restricted"""""""" through these MHC molecules.
Aims 2 and 3 will first, define an assay to measure the interaction of target HLA-A,B antigen with the surface of specific CTL and, second, use this assay to develop a completely defined in vitro system in which the interaction can be studied. As the interactions to be studied are of low affinity the methods to be used to detect binding will amplify effective or functional affinities by the construction of defined multivalent ligands using monoclonal antibodies against HLA-A,B and the variable T cell antigen receptor. This proposal aims to provide insight into a fundamental immunological process. It may provide formal proof of the identity of the variable antigen receptor of T cells and define in molecular terms the function of HLA-A,B. The methods developed may result in better assays for T cell responses that may have application in diagnosis in many clinical situations, particularly those involving the transplant recipient.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022039-04
Application #
3132654
Study Section
Immunobiology Study Section (IMB)
Project Start
1985-09-30
Project End
1990-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Illing, Patricia T; Pymm, Phillip; Croft, Nathan P et al. (2018) HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nat Commun 9:4693
Pugh, Jason L; Nemat-Gorgani, Neda; Norman, Paul J et al. (2018) Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol 200:1146-1158
Blokhuis, Jeroen H; Hilton, Hugo G; Guethlein, Lisbeth A et al. (2017) KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans. Immun Inflamm Dis 5:461-468
Hilton, Hugo G; McMurtrey, Curtis P; Han, Alex S et al. (2017) The Intergenic Recombinant HLA-B?46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Rep 19:1394-1405
Djaoud, Zakia; Guethlein, Lisbeth A; Horowitz, Amir et al. (2017) Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med 214:1827-1841
Hilton, Hugo G; Parham, Peter (2017) Missing or altered self: human NK cell receptors that recognize HLA-C. Immunogenetics 69:567-579
Hilton, Hugo G; Blokhuis, Jeroen H; Guethlein, Lisbeth A et al. (2017) Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C. J Immunol 198:1961-1973
Horowitz, Amir; Djaoud, Zakia; Nemat-Gorgani, Neda et al. (2016) Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol 1:
Hilton, Hugo G; Norman, Paul J; Nemat-Gorgani, Neda et al. (2015) Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population. PLoS Genet 11:e1005439
Hilton, Hugo G; Moesta, Achim K; Guethlein, Lisbeth A et al. (2015) The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay. J Immunol Methods 425:79-87

Showing the most recent 10 out of 81 publications